title: Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA.
abstract: OBJECTIVE
  To attain the effective local and sustained delivery of plasmid DNA (pDNA) encoding for a growth factor.
  
  
  METHODS
  We hypothesized that controlling the degradation rate of biomaterials encapsulating pDNA via concurrent physical dissociation of the cross-linked structure and hydrolytic chain breakage of polymers would allow one to significantly broaden the range of pDNA release rate. This hypothesis was examined using ionically cross-linked polysaccharide hydrogels which were previously designed to rapidly degrade via engineering of ionic cross-linking junction and partial oxidation of polysaccharide chains.
  
  
  RESULTS
  The hydrogel degradation rates were varied over the broad range, and pDNA release correlated with the gel degradation rate. Degradable hydrogels were used for the local and sustained delivery of a pDNA encoding for vascular endothelial growth factor (VEGF) in the ischemic hindlimbs of mice, and local pDNA release significantly improved the recovery of blood perfusion as compared with a bolus injection of VEGFencoding pDNA.
  
  
  CONCLUSIONS
  This strategy to control the hydrogel degradation rate may be useful in regulating the delivery of a broad array of macromolecular drugs, and subsequently improve their therapeutic efficacy.
authors.affiliation: Division of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.
authors.forename: Hyun Joon
authors.initials: HJ
authors.lastname: Kong
authors.forename: Eun Seok
authors.initials: ES
authors.lastname: Kim
authors.forename: Yen-Chen
authors.initials: YC
authors.lastname: Huang
authors.forename: David J
authors.initials: DJ
authors.lastname: Mooney
mesh_terms: D000464:Alginates / Q000737:chemistry; D000465:Algorithms; D000818:Animals; D003432:Cross-Linking Reagents; D004247:DNA / Q000008:administration & dosage* / Q000235:genetics; D003692:Delayed-Action Preparations; D015870:Gene Expression / Q000187:drug effects; D051379:Mice; D016688:Mice, Inbred NOD; D008970:Molecular Weight; D018919:Neovascularization, Physiologic / Q000235:genetics*; D010957:Plasmids / Q000008:administration & dosage* / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis / Q000235:genetics
chemical_list: D000464:Alginates; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D042461:Vascular Endothelial Growth Factor A; D004247:DNA